The current location of trastuzumab in the treatment of HER2 positive breast cancer

Abstract

Breast cancer is the most common countries of the European Union's cancer diagnosis. Screening measures and the introduction of new treatment options provide, despite the rising incidence of the disease stabilized mortality.

Keywords

• Breast cancer
• HER2 positive
• trastuzumab
• diagnosis
• metastatic carcinoma